Oracle Investment Management as of June 30, 2014
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 30 positions in its portfolio as reported in the June 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Accelr8 Technology Corporation | 17.0 | $140M | 5.4M | 26.00 | |
Tenet Healthcare Corporation | 8.7 | $71M | 1.5M | 46.94 | |
Acorda Therapeutics | 7.9 | $65M | 1.9M | 33.71 | |
Quidel Corporation | 7.8 | $65M | 2.9M | 22.11 | |
Mazor Robotics Ltd. equities | 6.7 | $55M | 3.2M | 17.57 | |
NxStage Medical | 6.5 | $54M | 3.7M | 14.37 | |
Thoratec Corporation | 6.2 | $51M | 1.5M | 34.86 | |
Opko Health (OPK) | 6.1 | $50M | 5.7M | 8.84 | |
Transition Therapeutics | 4.0 | $33M | 4.9M | 6.72 | |
Accuray Incorporated (ARAY) | 3.9 | $32M | 3.6M | 8.80 | |
Hansen Medical | 3.1 | $26M | 20M | 1.31 | |
Ironwood Pharmaceuticals (IRWD) | 3.0 | $25M | 1.6M | 15.33 | |
Repros Therapeutics | 2.7 | $22M | 1.3M | 17.30 | |
Tesaro | 2.4 | $20M | 634k | 31.11 | |
Pacific Biosciences of California (PACB) | 2.2 | $19M | 3.0M | 6.18 | |
Vermillion | 2.2 | $18M | 7.1M | 2.58 | |
WebMD Health | 1.8 | $15M | 300k | 48.30 | |
Biolase Technology | 1.6 | $14M | 6.1M | 2.20 | |
Intrexon | 1.1 | $9.3M | 369k | 25.13 | |
Gentiva Health Services | 1.1 | $9.1M | 602k | 15.06 | |
Bluebird Bio (BLUE) | 0.8 | $6.9M | 179k | 38.57 | |
Amarin Corporation (AMRN) | 0.8 | $6.5M | 3.7M | 1.76 | |
Derma Sciences | 0.7 | $5.7M | 493k | 11.56 | |
Gilead Sciences (GILD) | 0.5 | $4.1M | 50k | 82.91 | |
shares Agenus | 0.5 | $3.7M | 1.2M | 3.22 | |
Biogen Idec (BIIB) | 0.3 | $2.4M | 7.7k | 315.31 | |
Metabolix | 0.2 | $1.4M | 1.7M | 0.87 | |
Tonix Pharmaceuticls | 0.2 | $1.3M | 92k | 14.35 | |
GTx | 0.0 | $366k | 265k | 1.38 | |
Ladenburg Thalmann Financial Services | 0.0 | $352k | 112k | 3.15 |